AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

SAj Annual Awards

Beginning in 2014, SAj has presented awards on an annual basis for SAj Most Impactful Paper Award, SAj Best Peer Reviewer Award, and SAj Most Downloaded Paper at the AMERSA conference. Each awardee receives a glass trophy in recognition of their contributions to SAj.

SAj Most Impactful Paper Award

The SAj Most Impactful Paper Award is given annually to a published paper within SAj with a designation of the most impact to the field of addiction science within the previous two years. This award is nominated and awarded by the SAj Editorial Team.

2024[Not awarded]
2023[Not awarded]
2022Holly Hagle, PhDHagle HN, Martin M, Winograd R, Merlin J, Finnell DS, Bratberg JP, Gordon AJ, Johnson C, Levy S, MacLane-Baeder D, Northup R, Weinstein Z, Lum PJ. Dismantling racism against Black, Indigenous, and people of color across the substance use continuum: A position statement of the association for multidisciplinary education and research in substance use and addiction. Subst Abus. 2021;42(1):5-12. PMID: 33465013
2021Rachel SimonSimon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Subst Abus. 2020;41(4):519-525. PMID: 31638862
2020[Not awarded]
2019Joseph PalamarPalamar JJ, Le A, Acosta P. Posting, texting, and related social risk behavior while high. Subst Abus. 2020;41(3):382-390. PMID: 31382869; PMCID: PMC7122951
2018Randi Sokol, MD, MPH, MMedSokol R, Albanese C, Chaponis D, Early J, Maxted G, Morrill D, Poirier G, Puopolo F, Schuman-Olivier Z. Why use group visits for opioid use disorder treatment in primary care? A patient-centered qualitative study. Subst Abus. 2018 Jan 2;39(1):52-58. PMID: 28723302
2017Mallika Mundkur, MD, MPHMundkur ML, Gordon AJ, Kertesz SG. Will strict limits on opioid prescription duration prevent addiction? Advocating for evidence-based policymaking. Subst Abus. 2017 Jul-Sep;38(3):237-238. PMID: 28632485
2016Miriam Komaromy, MDKomaromy M, Duhigg D, Metcalf A, Carlson C, Kalishman S, Hayes L, Burke T, Thornton K, Arora S. Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders. Subst Abus. 2016;37(1):20-4. PMID: 26848803; PMCID: PMC4873719
2015Jessica J. Black, PhDBlack JJ, Chung T. Mechanisms of change in adolescent substance use treatment: how does treatment work? Subst Abus. 2014;35(4):344-51. PMID: 24901750; PMCID: PMC4257904
2014Conrad L. Woolsey, PhD, CHES, CC-AASPWoolsey CL, Barnes LB, Jacobson BH, Kensinger WS, Barry AE, Beck NC, Resnik AG, Evans MW Jr. Frequency of energy drink use predicts illicit prescription stimulant use. Subst Abus. 2014;35(1):96-103. PMID: 24588300

SAj Best Peer Reviewer Award

The SAj Best Peer Reviewer Award recognizes an external peer reviewer that, in the previous two years, provided narrative within their peer-reviews that gave feedback to authors that was thorough, considered the article within the context of current addiction literature, and provided specific recommendations to improve the paper. This award is nominated and awarded by the SAj Editorial Team.

2024Joseph Mandato, Medical Student
2023Rebekah Halmo, MSW, LCSW and Adèle Morvannou, PhD
2022[Not awarded]
2021Frank Schwebel, PhD and Elena Stein, MS
2020[Not awarded]
2019Ana Holtey, DO
2018Sara Bartel and Gwen T. Lapham. PhD, MPH, MSW
2017Matthew Neuman, PhD
2016Diana S. Hoover, PhD
2015Jeffrey Baxter, MD
2014Joanna L. Starrels, MD, MS

SAj Most Downloaded Paper

The SAj Most Downloaded Paper Award is given to the paper with the most full-text downloads within the previous two years according to data from our publisher.

2024Leslie Suen, MD, MASSuen LW, Incze M, Simon C, Englander H, Bratberg J, Groves Scott G, Winograd R. Methadone’s Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction). Subst Use Addctn J. 2024 Jul;45(3):337-345. doi: 10.1177/29767342241255480. Epub 2024 May 28. PMID: 38804606
2023[Not awarded]
2022Viktoriya Broyan, MSBroyan VR, Brar JK, Allgaier Student T, Allgaier JT. Long-term buprenorphine treatment for kratom use disorder: A case series. Subst Abus. 2022;43(1):763-766. PMID: 35112990
2021S.J. Bartel, BABartel SJ, Sherry SB, Stewart SH. Self-isolation: A significant contributor to cannabis use during the COVID-19 pandemic. Subst Abus. 2020;41(4):409-412. PMID: 33044893
2020Traci C. Green, PhD, MScGreen TC, Bratberg J, Finnell DS. Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment. Subst Abus. 2020;41(2):147-149. PMID: 32314951
2019Stefan Kertesz, MD, MScKertesz SG, Satel SL, DeMicco J, Dart RC, Alford DP. Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention. Subst Abus. 2019;40(4):466-468. PMID: 31361588
2018Stefan Kertesz, MD, MScKertesz SG. Turning the tide or riptide? The changing opioid epidemic. Subst Abus. 2017 Jan-Mar;38(1):3-8. PMID: 27858590
2017Stefan Kertesz, MD, MScKertesz SG. Turning the tide or riptide? The changing opioid epidemic. Subst Abus. 2017 Jan-Mar;38(1):3-8. PMID: 27858590
2016Ingrid A. Binswanger, MD, MPH, MSBinswanger IA, Gordon AJ. From risk reduction to implementation: Addressing the opioid epidemic and continued challenges to our field. Subst Abus. 2016;37(1):1-3. PMID: 26820257
2015Christian Hopfer, MDHopfer C. Implications of marijuana legalization for adolescent substance use. Subst Abus. 2014;35(4):331-5. PMID: 25127003; PMCID: PMC4308295
2014Lauren M. Broyles, PhD, RNBroyles LM, Binswanger IA, Jenkins JA, Finnell DS, Faseru B, Cavaiola A, Pugatch M, Gordon AJ. Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abus. 2014;35(3):217-21. PMID: 24911031; PMCID: PMC6042508

Copyright © 2025
Site by: web360